BARDA - “Expanding the use of therapeutics to paediatric populations”
Interesting …. could BARDA support Rexlemestrocel-L (aka REVASCOR) for the treatment of children with hypoplastic left heart syndrome (HLHS) ? Seems like Mesoblast’s therapeutic paediatric treatment would qualify for BARDA support ?
GLTAH
BARDA - “Expanding the use of therapeutics to paediatric...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.010(0.92%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.12 | $1.07 | $1.659M | 1.515M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 8899 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 106694 | 15 |
View Market Depth
| Last trade - 12.23pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |